These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7890014)

  • 1. The effect of probucol and vitamin E treatment on the oxidation of low-density lipoprotein and forearm vascular responses in humans.
    McDowell IF; Brennan GM; McEneny J; Young IS; Nicholls DP; McVeigh GE; Bruce I; Trimble ER; Johnston GD
    Eur J Clin Invest; 1994 Nov; 24(11):759-65. PubMed ID: 7890014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of effects of probucol versus vitamin E on ex vivo oxidation susceptibility of lipoproteins in hyperlipoproteinemia.
    Dujovne CA; Harris WS; Gerrond LL; Fan J; Muzio F
    Am J Cardiol; 1994 Jul; 74(1):38-42. PubMed ID: 8017303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters.
    El-Swefy S; Schaefer EJ; Seman LJ; van Dongen D; Sevanian A; Smith DE; Ordovas JM; El-Sweidy M; Meydani M
    Atherosclerosis; 2000 Apr; 149(2):277-86. PubMed ID: 10729377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of simvastatin and probucol in hypercholesterolemia (Simvastatin Multicenter Study Group II).
    Pietro DA; Alexander S; Mantell G; Staggers JE; Cook TJ
    Am J Cardiol; 1989 Mar; 63(11):682-6. PubMed ID: 2646895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of vitamin E administration on nitric oxide function in subjects with hypercholesterolaemia.
    Green D; O'Driscoll G; Rankin JM; Maiorana AJ; Taylor RR
    Clin Sci (Lond); 1998 Sep; 95(3):361-7. PubMed ID: 9730857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of simvastatin combined with different antioxidant vitamin regimens on serum lipid profile in patients with low HDL cholesterol levels].
    Pirat B; Korkmaz ME; Eroğlu S; Tayfun E; Yildirir A; Uluçam M; Ozin B; Müderrisoğlu H
    Anadolu Kardiyol Derg; 2004 Dec; 4(4):318-22. PubMed ID: 15590360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.
    Feldman DL; Mogelesky TC; Sharif R; Sawyer WK; Jeune M; Hu CW; Leonards KS; Prescott MF
    Atherosclerosis; 1999 Jun; 144(2):343-55. PubMed ID: 10407495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBPRCA Astra Award. Therapeutic restoration of endothelial function in hypercholesterolaemic subjects: effect of fish oils.
    Chin JP; Dart AM
    Clin Exp Pharmacol Physiol; 1994 Oct; 21(10):749-55. PubMed ID: 7867225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemia. The Lovastatin Study Group IV.
    Am J Cardiol; 1990 Sep; 66(8):22B-30B. PubMed ID: 2206033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical investigation on the hypolipidemic effect of simvastatin versus probucol in hemodialysis patients.
    Fiorini F; Patrone E; Castelluccio A
    Clin Ter; 1994 Sep; 145(9):213-7. PubMed ID: 7813167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of low-dose probucol therapy on LDL oxidation and the plasma lipoprotein profile in male volunteers.
    Cristol LS; Jialal I; Grundy SM
    Atherosclerosis; 1992 Nov; 97(1):11-20. PubMed ID: 1445490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).
    Bays HE; Dujovne CA; McGovern ME; White TE; Kashyap ML; Hutcheson AG; Crouse JR;
    Am J Cardiol; 2003 Mar; 91(6):667-72. PubMed ID: 12633795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline lipoprotein lipids and low-density lipoprotein cholesterol response to prescription omega-3 acid ethyl ester added to Simvastatin therapy.
    Maki KC; Dicklin MR; Davidson MH; Doyle RT; Ballantyne CM;
    Am J Cardiol; 2010 May; 105(10):1409-12. PubMed ID: 20451686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of low-density-lipoprotein lowering with statins.
    Rosenson RS; Stein JH
    Lancet; 1994 Sep; 344(8923):683. PubMed ID: 7915366
    [No Abstract]   [Full Text] [Related]  

  • 16. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis.
    Lee HS; Jeong JY; Kim BC; Kim YS; Zhang YZ; Chung HK
    Kidney Int; 1997 Apr; 51(4):1151-9. PubMed ID: 9083281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome.
    Vega GL; Ma PT; Cater NB; Filipchuk N; Meguro S; Garcia-Garcia AB; Grundy SM
    Am J Cardiol; 2003 Apr; 91(8):956-60. PubMed ID: 12686335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month.
    O'Driscoll G; Green D; Taylor RR
    Circulation; 1997 Mar; 95(5):1126-31. PubMed ID: 9054840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia.
    Gilligan DM; Sack MN; Guetta V; Casino PR; Quyyumi AA; Rader DJ; Panza JA; Cannon RO
    J Am Coll Cardiol; 1994 Dec; 24(7):1611-7. PubMed ID: 7963105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients.
    Hamilton SJ; Chew GT; Davis TM; Watts GF
    Clin Sci (Lond); 2010 Feb; 118(10):607-15. PubMed ID: 20047560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.